LARS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.338000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.743400E-01
Normal-vs-Stage2
4.987600E-01
Normal-vs-Stage3
6.478400E-02
Normal-vs-Stage4
6.001800E-01
Stage1-vs-Stage2
7.243600E-01
Stage1-vs-Stage3
6.964000E-02
Stage1-vs-Stage4
2.560000E-01
Stage2-vs-Stage3
1.415410E-01
Stage2-vs-Stage4
2.267400E-01
Stage3-vs-Stage4
2.103700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.308000E-01
Normal-vs-AfricanAmerican
3.755400E-01
Normal-vs-Asian
4.354600E-01
Caucasian-vs-AfricanAmerican
8.698200E-01
Caucasian-vs-Asian
3.365800E-01
AfricanAmerican-vs-Asian
6.977600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.810200E-01
Normal-vs-Female
4.922400E-01
Male-vs-Female
7.595600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.985400E-01
Normal-vs-Age(41-60Yrs)
9.362800E-01
Normal-vs-Age(61-80Yrs)
3.848400E-01
Normal-vs-Age(81-100Yrs)
5.749200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.352200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.192400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.081000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.883400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.618200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.606200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.885200E-01
Normal-vs-Daily Drinker
3.499200E-01
Normal-vs-Weekly Drinker
8.621800E-02
Normal-vs-Occasional Drinker
9.895600E-01
Normal-vs-Social Drinker
9.993400E-01
Non Drinker-vs-Daily Drinker
4.512600E-01
Non Drinker-vs-Weekly Drinker
1.455180E-01
Non Drinker-vs-Occasional Drinker
2.880400E-01
Non Drinker-vs-Social Drinker
2.902600E-01
Daily Drinker-vs-Weekly Drinker
4.321800E-01
Daily Drinker-vs-Occasional Drinker
8.658400E-02
Daily Drinker-vs-Social Drinker
8.497700E-02
Weekly Drinker-vs-Occasional Drinker
1.665860E-02
Weekly Drinker-vs-Social Drinker
1.180380E-02
Occasional Drinker-vs-Social Drinker
9.821800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.864150E-01
Normal-vs-Grade 2
5.176800E-01
Normal-vs-Grade 3
6.665700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.668600E-01
Grade 1-vs-Grade 3
3.851200E-01
Grade 1-vs-Grade 4
1.864150E-01
Grade 2-vs-Grade 3
2.781000E-01
Grade 2-vs-Grade 4
5.176800E-01
Grade 3-vs-Grade 4
6.665700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.139200E-01
Normal-vs-NonDiabetic
5.649200E-01
Diabetic-vs-NonDiabetic
5.265000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.263000E-01
Normal-vs-NoPancreatitis
5.701600E-01
Pancreatitis-vs-NoPancreatitis
7.954200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.850600E-01
Normal-vs-N1
4.812800E-01
N0-vs-N1
2.969000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.207200E-01
Normal-vs-TP53-NonMutant
6.155000E-01
TP53-Mutant-vs-TP53-NonMutant
3.264800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
